Gilead acquiring synthetic CAR T company Cell Design

Gilead Sciences Inc. (NASDAQ:GILD) will acquire Cell Design Labs Inc. (San Francisco, Calif.) for $175 million up front, plus up to $322 million in milestones

Read the full 252 word article

User Sign In